Prevalence and risk factors of dry eye disease in patients treated with aromatase inhibitors for breast cancer-Reference-Cited by-同舟云学术

Prevalence and risk factors of dry eye disease in patients treated with aromatase inhibitors for breast cancer

Published:2023-09-12 Issue: Volume: Page:1-5
ISSN:0816-4622
Container-title:Clinical and Experimental Optometry
language:en
Short-container-title:Clinical and Experimental Optometry

Author:

Machairoudia Genovefa¹,Kazantzis Dimitrios¹,Chatziralli Irini¹^ORCID,Kampoli Katerina²,Ntavatzikos Anastasios²,Theodossiadis Panagiotis¹,Koumarianou Anna²

Affiliation:

1. 2nd Department of Ophthalmology, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece

2. Hematology Oncology Unit, 4th Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece

Publisher

Informa UK Limited

Subject

Optometry,Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/08164622.2023.2239247

Reference28 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Aromatase Inhibitors in Breast Cancer

3. Detection of Oestrogen receptors (ER) α and β in conjunctiva, lacrimal gland, and tarsal plates

4. Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease

5. Identification of androgen receptor protein and 5alpha -reductase mRNA in human ocular tissues

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coverings on Pitfall Traps Influence the Abundance of Ground-Dwelling Arthropods;Diversity;2023-12-26